SG4695G - Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases - Google Patents

Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases

Info

Publication number
SG4695G
SG4695G SG4695A SG4695A SG4695G SG 4695 G SG4695 G SG 4695G SG 4695 A SG4695 A SG 4695A SG 4695 A SG4695 A SG 4695A SG 4695 G SG4695 G SG 4695G
Authority
SG
Singapore
Prior art keywords
oxo
kidney
diseases
treatment
imidazolidine derivatives
Prior art date
Application number
SG4695A
Inventor
Isao Yamaguchi
Shinsuke Nishiyama
Masami Kubo
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Priority to SG4695A priority Critical patent/SG4695G/en
Publication of SG4695G publication Critical patent/SG4695G/en

Links

SG4695A 1986-12-12 1995-01-13 Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases SG4695G (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SG4695A SG4695G (en) 1986-12-12 1995-01-13 Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP29711386 1986-12-12
SG4695A SG4695G (en) 1986-12-12 1995-01-13 Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases

Publications (1)

Publication Number Publication Date
SG4695G true SG4695G (en) 1995-06-16

Family

ID=26561001

Family Applications (1)

Application Number Title Priority Date Filing Date
SG4695A SG4695G (en) 1986-12-12 1995-01-13 Use of 2-oxo-imidazolidine derivatives in the treatment of kidney-diseases

Country Status (1)

Country Link
SG (1) SG4695G (en)

Similar Documents

Publication Publication Date Title
EP0330496A3 (en) Skin treatment composition
EP0278173A3 (en) Use of heterocyclic derivatives in the treatment of depressions
IL81175A0 (en) Human preproinsulin-like factor i
PT84704A (en) Thiolactam-n-acetic derivatives their production and use
EP0275668A3 (en) Use of ketone derivatives in the treatment of cognitive disorders
GB8621869D0 (en) Treatment
ZA863900B (en) Use of benzopyran compounds in the treatment of incontinence
EP0255801A3 (en) Anilinotriazines and their use
ZA879505B (en) Flyslag treatment
GB2203645B (en) Improvements in the treatment of hair
GB8714972D0 (en) Medical treatment
GB8908843D0 (en) Improvements in or relating to the treatment of surfaces
GB2195250B (en) Medical vapourizer
GB8617623D0 (en) Treatment
ZA899304B (en) Use of benzopyran derivatives in the treatment of epilepsy
EP0407016A3 (en) Use of benzodioxinopyrrole derivatives in the treatment of anxiety
EP0269024A3 (en) Use of 3-methyl-4-oxothiazolidin-2-ylidene-acetamide derivatives in the treatment of aids
IL89998A0 (en) Use of gonadoliberin derivatives in the treatment of tumours
GB8615669D0 (en) Treatment
ZA883253B (en) Improvements in the treatment of sand
EP0254777A3 (en) Use of imidazolinylaminoisoindolines and related compounds in the treatment of hyperglycaemia
GB2188312B (en) Improvements in or relating to the treatment of waters
GB8616274D0 (en) Treatment
GB8619096D0 (en) Treatment
GB8627071D0 (en) Treatment